Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
The Journal of Dermatological Treatment
|
August 9, 2021
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis
Kim Papp, Zygmunt Adamski, Lyn Guenther, et al.
Journal of Cutaneous Medicine and Surgery
|
November 11, 2015
Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity
Vincent Richer, Camille Roubille, Patrick Fleming, et al.
Journal of the American Academy of Dermatology
|
October 18, 2024
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
Melissa Piliang, Charles Lynde, Brett King, et al.
Immunotherapy
|
July 5, 2023
A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areata
Brett King, Xingqi Zhang, Walter Gubelin Harcha, et al.
Lancet (London, England)
|
April 16, 2023
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
Brett King, Xingqi Zhang, Walter Gubelin Harcha, et al.
Dermatology and Therapy
|
February 12, 2026
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies
Andrew Blauvelt, Leon Kircik, Eric L Simpson, et al.
Journal of Cutaneous Medicine and Surgery
|
September 15, 2017
An Open Letter to Health Canada
Kim Papp, Lorne Albrecht, Kirk Barber, et al.
Frontiers in Medicine
|
September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
Michelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
Journal of the American Academy of Dermatology
|
February 26, 2019
Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne
Jerry Tan, Diane Thiboutot, Georg Popp, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
February 24, 2015
Insights and advances in chronic urticaria: a Canadian perspective
Gordon Sussman, Jacques Hébert, Wayne Gulliver, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
The Journal of Dermatological Treatment
|
August 9, 2021
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis
Kim Papp, Zygmunt Adamski, Lyn Guenther, et al.
Journal of Cutaneous Medicine and Surgery
|
November 11, 2015
Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity
Vincent Richer, Camille Roubille, Patrick Fleming, et al.
Journal of the American Academy of Dermatology
|
October 18, 2024
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
Melissa Piliang, Charles Lynde, Brett King, et al.
Immunotherapy
|
July 5, 2023
A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areata
Brett King, Xingqi Zhang, Walter Gubelin Harcha, et al.
Lancet (London, England)
|
April 16, 2023
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
Brett King, Xingqi Zhang, Walter Gubelin Harcha, et al.
Dermatology and Therapy
|
February 12, 2026
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies
Andrew Blauvelt, Leon Kircik, Eric L Simpson, et al.
Journal of Cutaneous Medicine and Surgery
|
September 15, 2017
An Open Letter to Health Canada
Kim Papp, Lorne Albrecht, Kirk Barber, et al.
Frontiers in Medicine
|
September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
Michelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
Journal of the American Academy of Dermatology
|
February 26, 2019
Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne
Jerry Tan, Diane Thiboutot, Georg Popp, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
February 24, 2015
Insights and advances in chronic urticaria: a Canadian perspective
Gordon Sussman, Jacques Hébert, Wayne Gulliver, et al.
Page
of 15